We know pharmaceutical marketing is complex, and it’s also quite rewarding. The rich, competitively informative datasets we work with are envied across industries. Just having the data isn’t enough. The organizations who know how to unlock the promise and truly use the data in their media strategies are the ones who will lead.
The first four principles I uncovered in the first two blog posts of this series share a common requirement: data must move. That’s when pharma marketing stops behaving like campaigns and begins operating as an adaptive system.
This blog post, the final in the series, digs deeper into the data challenges we face throughout healthcare and explores how a well-designed system helps all stakeholders.
5. Data must flow bidirectionally, and it must be consumable.
Pharma marketing sits at the intersection of extraordinary data availability and real operational friction. Claims data, persistent identifiers such as the national provider identifier (NPI), and rich engagement signals allow us to understand behavior across paid, owned, and field touchpoints at an individual level.
But availability is not the challenge. Usability is.
One of the most common mistakes marketers make is assuming that because we understand the data, everyone else should consume it the same way we do. We bombard reps with engagement reports, website activity summaries, paid media exposure logs, and CRM metrics because we can generate them and they make sense to us.
That approach rarely works because the objective isn’t visibility. It’s action.
Field teams don’t need more data. They need the right data, delivered at the right moment, in a form that aligns with how they actually work. They need to be able to interpret and understand it in order to use the insights we know are in there.
Establishing a sales rep “data injection” strategy is just as important as sharing the data itself.
For some reps, that may be a simple dashboard reviewed weekly. For others, it could be a chatbot queried before a call. In many cases, the most effective approach is embedding insight directly into the front page of a detail or CRM workflow, surfaced as a clear next best action before the visit even begins.
Here’s where AI can handle the repetitive, patterned tasks. When AI is embedded into your foundation, marketers and field reps alike begin to use it as a co-architect, a valuable team member.
Reps now use their emotional intelligence and empathy, and marketers dig into their creativity and storytelling.
The same principle applies in the opposite direction, and this is where I’ve seen organizations often struggle even more.
Information flowing from rep to marketer is inherently messier. It’s qualitative, contextual, and does not always conform to clean schemas. Because of that, it’s often undervalued or ignored.
The real power emerges when reps understand that the signals they provide back into the system pay dividends far beyond a single call. When activated effectively, that information results in softer targets, better intelligence, and scalable impact that no individual interaction could ever achieve alone.
The sweet spot is alignment.
- Reps must trust that the information they share will return to them as better prioritization, more relevant messaging, and more productive conversations
- Marketers must design systems that respect how field teams operate while still capturing the signal required to optimize the broader ecosystem
When bidirectional data flow works, personalization stops being a tactic and becomes an operating model. Paid, owned, and field efforts reinforce one another. Each interaction improves the next, and the system gets smarter over time.
When data becomes an operating model.
Pharmaceutical marketing is often described as constrained by regulation and complexity. In reality, it’s one of the few industries where outcomes-driven, data-first marketing can be executed with real rigor.
The organizations that win will not be those with the most data. They will be the ones that connect it, interpret it, and act on it faster than everyone else.
When data flows in both directions between media, marketers, and field teams, personalization stops being a tactic and becomes an operating model. Each interaction improves the next, the system learns, and the outcomes compound.
That philosophy sits at the center of MERGE’s Integrated Outcomes approach: designing marketing ecosystems that continuously learn, adapt, and improve how people experience healthcare.
Because in a category defined by improving human lives, progress belongs to organizations willing to test, learn, and act with intent.
